Drugs / IR103
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02366026 | Jun 2017 → Jun 2019 | HIV infectious disease | Immune Response BioPharma, Inc. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IR103 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02366026 ↗ |
| Modality | Vaccine | “IR103 Vaccine contain the same active component as REMUNE®” NCT02366026 ↗ |